{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:49:06Z","timestamp":1791582546202,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.vph.2026.107707","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:08:15Z","timestamp":1790348895000},"page":"107707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Beyond catecholamine escalation: Receptor desensitization and endogenous vasopressor failure, and extracorporeal circuit biocompatibility after cardiopulmonary bypass\u2014A narrative review"],"prefix":"10.1016","volume":"165","author":[{"given":"Ignazio","family":"Condello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Dell'Aquila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Condello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Totaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"El Dsouki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Prapas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Katsavrias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"D\u2019Onofrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirav","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kalimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Gaudino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Maria","family":"Calafiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.vph.2026.107707_bb0025","doi-asserted-by":"crossref","first-page":"F931","DOI":"10.1152\/ajprenal.00604.2013","article-title":"The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors","volume":"306","author":"Juul","year":"2014","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"2","key":"10.1016\/j.vph.2026.107707_bb0030","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.2337\/dbi15-0037","article-title":"Response to comment on Patel et al. ACE2 deficiency worsens epicardial adipose tissue inflammation and cardiac dysfunction in response to diet-induced obesity. Diabetes 2016;65:85-95","volume":"65","author":"Patel","year":"2016","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.vph.2026.107707_bb0035","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","article-title":"Role of the ACE2\/angiotensin 1-7 axis of the renin-angiotensin system in heart failure","volume":"118","author":"Patel","year":"2016","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.vph.2026.107707_bb0005","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/cc2337","article-title":"Science review: vasopressin and the cardiovascular system part 1--receptor physiology","volume":"7","author":"Holmes","year":"2003","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.vph.2026.107707_bb0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/cc2338","article-title":"Science review: vasopressin and the cardiovascular system part 2 - clinical physiology","volume":"8","author":"Holmes","year":"2004","journal-title":"Crit. Care"},{"issue":"12","key":"10.1016\/j.vph.2026.107707_bb0015","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/sj.ki.5000432","article-title":"Vasopressin receptor antagonists","volume":"69","author":"Greenberg","year":"2006","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.vph.2026.107707_bb0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bpa.2008.03.003","article-title":"Physiology of the vasopressin receptors","volume":"22","author":"Maybauer","year":"2008","journal-title":"Best Pract. Res. Clin. Anaesthesiol."},{"key":"10.1016\/j.vph.2026.107707_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105272","article-title":"Arginine vasopressin receptor 2 activation promotes microvascular permeability in sepsis","volume":"163","author":"Lopez","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.vph.2026.107707_bb0085","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s13054-020-02928-0","article-title":"Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series","volume":"24","author":"Zangrillo","year":"2020","journal-title":"Crit. Care"},{"issue":"5","key":"10.1016\/j.vph.2026.107707_bb0090","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/08850666221145864","article-title":"Angiotensin II for vasodilatory hypotension in patients requiring mechanical circulatory support","volume":"38","author":"Wieruszewski","year":"2023","journal-title":"J. Intensive Care Med."},{"issue":"1","key":"10.1016\/j.vph.2026.107707_bb0095","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13054-023-04446-1","article-title":"Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial","volume":"27","author":"Wieruszewski","year":"2023","journal-title":"Crit. Care"},{"issue":"2","key":"10.1016\/j.vph.2026.107707_bb0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccc.2018.11.003","article-title":"Angiotensin II in vasodilatory shock","volume":"35","author":"Wakefield","year":"2019","journal-title":"Crit. Care Clin."},{"issue":"1","key":"10.1016\/j.vph.2026.107707_bb0065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cardiores.2005.09.011","article-title":"Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease","volume":"69","author":"Penela","year":"2006","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.vph.2026.107707_bb0100","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0003-4975(96)01367-7","article-title":"Intermittent warm blood cardioplegia preserves myocardial beta-adrenergic receptor function","volume":"63","author":"Chello","year":"1997","journal-title":"Ann. Thorac. Surg."},{"issue":"8","key":"10.1016\/j.vph.2026.107707_bb0105","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1177\/0267659120968364","article-title":"Air, inflammation and biocompatibility of the extracorporeal circuits","volume":"36","author":"Condello","year":"2021","journal-title":"Perfusion"},{"issue":"2","key":"10.1016\/j.vph.2026.107707_bb0060","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0003-4975(03)01510-8","article-title":"Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery","volume":"77","author":"Levin","year":"2004","journal-title":"Ann. Thorac. Surg."},{"issue":"5721","key":"10.1016\/j.vph.2026.107707_bb0165","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1126\/science.1109237","article-title":"Transduction of receptor signals by beta-arrestins","volume":"308","author":"Lefkowitz","year":"2005","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.vph.2026.107707_bb0170","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrm908","article-title":"Seven-transmembrane receptors","volume":"3","author":"Pierce","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.vph.2026.107707_bb0175","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.pharmtox.010909.105800","article-title":"Molecular mechanism of \u03b2-arrestin-biased agonism at seven-transmembrane receptors","volume":"52","author":"Reiter","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.vph.2026.107707_bb0180","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev.neuro.27.070203.144206","article-title":"Desensitization of G protein-coupled receptors and neuronal functions","volume":"27","author":"Gainetdinov","year":"2004","journal-title":"Annu. Rev. Neurosci."},{"issue":"6","key":"10.1016\/j.vph.2026.107707_bb0040","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/cvr\/cvaa078","article-title":"The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2","volume":"116","author":"Chen","year":"2020","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.vph.2026.107707_bb0055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12933-021-01275-w","article-title":"Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system","volume":"20","author":"Herman-Edelstein","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.vph.2026.107707_bb0245","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/angiotensin-(1-7)\/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"issue":"21","key":"10.1016\/j.vph.2026.107707_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11216407","article-title":"Vasoplegic syndrome after cardiopulmonary bypass in cardiovascular surgery: pathophysiology and management in critical care","volume":"11","author":"Ltaief","year":"2022","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.vph.2026.107707_bb0120","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13054-018-2102-1","article-title":"Definitions and pathophysiology of vasoplegic shock","volume":"22","author":"Lambden","year":"2018","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.vph.2026.107707_bb0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13054-020-2743-8","article-title":"Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options","volume":"24","author":"Busse","year":"2020","journal-title":"Crit. Care"},{"issue":"10","key":"10.1016\/j.vph.2026.107707_bb0130","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1111\/jocs.15805","article-title":"Vasoplegic syndrome after cardiovascular surgery: a review of pathophysiology and outcome-oriented therapeutic management","volume":"36","author":"Datt","year":"2021","journal-title":"J. Card. Surg."},{"issue":"7","key":"10.1016\/j.vph.2026.107707_bb0135","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1053\/j.jvca.2025.02.047","article-title":"Vasoplegic syndrome in cardiac surgery: anarrative review of etiologic mechanisms and therapeutic options","volume":"39","author":"Polyak","year":"2025","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"issue":"2","key":"10.1016\/j.vph.2026.107707_bb0140","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.chest.2017.12.021","article-title":"Management of refractory vasodilatory shock","volume":"154","author":"Jentzer","year":"2018","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.vph.2026.107707_bb0145","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13054-018-1967-3","article-title":"Vasoplegia treatments: the past, the present, and the future","volume":"22","author":"Levy","year":"2018","journal-title":"Crit. Care"},{"issue":"5","key":"10.1016\/j.vph.2026.107707_bb0150","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.vph.2026.107707_bb0155","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/CCM.0000000000003092","article-title":"Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II","volume":"46","author":"Tumlin","year":"2018","journal-title":"Crit. Care Med."},{"issue":"3","key":"10.1016\/j.vph.2026.107707_bb0185","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00424-007-0212-8","article-title":"The endothelial glycocalyx: composition, functions, and visualization","volume":"454","author":"Reitsma","year":"2007","journal-title":"Pflugers Arch."},{"issue":"6","key":"10.1016\/j.vph.2026.107707_bb0190","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00395-010-0118-z","article-title":"Endothelial glycocalyx and coronary vascular permeability: the fringe benefit","volume":"105","author":"Becker","year":"2010","journal-title":"Basic Res. Cardiol."},{"issue":"4","key":"10.1016\/j.vph.2026.107707_bb0195","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/ALN.0b013e3181863117","article-title":"A rational approach to perioperative fluid management","volume":"109","author":"Chappell","year":"2008","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.vph.2026.107707_bb0200","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13054-018-2292-6","article-title":"The glycocalyx: a novel diagnostic and therapeutic target in sepsis","volume":"23","author":"Uchimido","year":"2019","journal-title":"Crit. Care"},{"issue":"7","key":"10.1016\/j.vph.2026.107707_bb0205","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/anae.12661","article-title":"The endothelial glycocalyx: a review of the vascular barrier","volume":"69","author":"Alphonsus","year":"2014","journal-title":"Anaesthesia"},{"issue":"3","key":"10.1016\/j.vph.2026.107707_bb0210","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/SHK.0000000000000473","article-title":"The endothelium in sepsis","volume":"45","author":"Ince","year":"2016","journal-title":"Shock"},{"issue":"4","key":"10.1016\/j.vph.2026.107707_bb0235","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1053\/j.jvca.2019.09.004","article-title":"Vasoplegia after cardiac surgery is associated with endothelial glycocalyx alterations","volume":"34","author":"Abou-Arab","year":"2020","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"issue":"5","key":"10.1016\/j.vph.2026.107707_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/jcdd10050213","article-title":"Endothelial dysfunction in patients undergoing cardiac surgery: anarrative review and clinical implications","volume":"10","author":"Kne\u017eevi\u0107","year":"2023","journal-title":"J. Cardiovasc. Dev. Dis."},{"issue":"4","key":"10.1016\/j.vph.2026.107707_bb0220","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/cc8224","article-title":"Bench-to-bedside review: vasopressin in the management of septic shock","volume":"15","author":"Russell","year":"2011","journal-title":"Crit. Care"},{"issue":"9","key":"10.1016\/j.vph.2026.107707_bb0225","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.vph.2026.107707_bb0230","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1590\/S0102-76382009000400005","article-title":"Methylene blue for vasoplegic syndrome treatment in heart surgery: fifteen years of questions, answers, doubts and certainties","volume":"24","author":"Evora","year":"2009","journal-title":"Rev. Bras. Cir. Cardiovasc."},{"key":"10.1016\/j.vph.2026.107707_bb0115","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1053\/j.jvca.2018.08.017","article-title":"Hydroxocobalamin for the treatment of vasoplegia, a review of current literature and considerations for use","volume":"33","author":"Shapeton","year":"2019","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"issue":"4","key":"10.1016\/j.vph.2026.107707_bb0160","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1053\/j.jvca.2018.08.017","article-title":"Hydroxocobalamin for the treatment of vasoplegia: a review of current literature and considerations for use","volume":"33","author":"Shapeton","year":"2019","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"issue":"10","key":"10.1016\/j.vph.2026.107707_bb0045","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s11748-017-0789-6","article-title":"Risk assessment and outcomes of vasoplegia after cardiac surgery","volume":"65","author":"Tsiouris","year":"2017","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"issue":"5","key":"10.1016\/j.vph.2026.107707_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/jcm15051953","article-title":"Modulation of the vasopressin system in distributive and cardiogenic shock: theoretical principles and practical applications","volume":"15","author":"Mauriello","year":"2026","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.vph.2026.107707_bb0075","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MAJ.0000000000000341","article-title":"Cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment","volume":"349","author":"Omar","year":"2015","journal-title":"Am. J. Med. Sci."},{"issue":"9453","key":"10.1016\/j.vph.2026.107707_bb0215","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(04)17667-8","article-title":"Septic shock","volume":"365","author":"Annane","year":"2005","journal-title":"Lancet"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189126001278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189126001278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:54:32Z","timestamp":1791579272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189126001278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":49,"alternative-id":["S1537189126001278"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2026.107707","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond catecholamine escalation: Receptor desensitization and endogenous vasopressor failure, and extracorporeal circuit biocompatibility after cardiopulmonary bypass\u2014A narrative review","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2026.107707","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107707"}}